Fig. 6
From: Advances of medical nanorobots for future cancer treatments
A Schematic illustration of the nanorobot HApt-tFNA incorporating HER2 in the HER2-HApt-tFNA complex and internalizing the complex into human mammary gland adenocarcinoma cells. The complex degrades within lysosomes, which suppresses cell proliferation and induces cell death. Modified and reprinted from ref. [249]. Reproduced with permission. Copyright 2019, American Chemical Society. B The effects of the cancer microenvironment on the development of drug resistance, and the ultrasound-responsive alkaline nanorobots (AN-DSP) for enhancing anticancer effects. Modified and reprinted from ref. [268]. Reproduced with permission. Copyright 2020, Royal Society of Chemistry